WUXI BIO (02269.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec24

WuXi Biologics Wins 2025 Hong Kong ESG Report Award

03:55

Dec19

WuXi Biologics Receives CDP Climate Change and Water Security 'A' Rating

04:26

Dec2

WuXi Biologics Signs Strategic Cooperation Memorandum with Qatar Free Zone Authority

04:22

Nov29

WuXi Biologics and Its Subsidiary Donate HKD 10 Million for Disaster Relief

07:20

Nov28

WuXi Biologics Issues 10.369 Million Shares Under Share Plan

13:09

Nov25

WuXi XDC Cayman to Hold Special Shareholders Meeting to Discuss Service Agreements with WuXi Biologics and WuXi AppTec

22:56

Schedules & Filings

Schedules

Filings

Aug19

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 5.447 B, Net Income 1.28 B, EPS 0.3019

Mar25

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 5.373 B, Net Income 987.79 M, EPS 0.2324

Aug21

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 4.607 B, Net Income 805.4 M, EPS 0.1871

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change